136 related articles for article (PubMed ID: 1288908)
21. Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson-White syndrome.
Neuss H; Buss J; Schlepper M; Berthold R; Mitrović V; Krämer A; Musial WJ
Eur Heart J; 1983 May; 4(5):347-53. PubMed ID: 6617681
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency current catheter ablation of accessory atrioventricular pathways.
Trajkov I; Kovacevic D; Boskov V; Poposka L; Gjorgov N
Prilozi; 2006 Dec; 27(2):71-87. PubMed ID: 17211293
[TBL] [Abstract][Full Text] [Related]
23. The electrophysiologic effects of intravenous lidocaine in the Wolff-Parkinson-White syndrome.
Barrett PA; Laks MM; Mandel WJ; Yamaguchi I
Am Heart J; 1980 Jul; 100(1):23-33. PubMed ID: 7386363
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiologic characteristics and radiofrequency catheter ablation in children with Wolff-Parkinson-White syndrome.
Lee PC; Hwang B; Chen YJ; Tai CT; Chen SA; Chiang CE
Pacing Clin Electrophysiol; 2006 May; 29(5):490-5. PubMed ID: 16689844
[TBL] [Abstract][Full Text] [Related]
25. Characterization of retrograde conduction by direct endocardial recording from an accessory atrioventricular pathway.
O'Callaghan WG; Colavita PG; Kay GN; Ellenbogen KA; Gilbert MR; German LD
J Am Coll Cardiol; 1986 Jan; 7(1):167-71. PubMed ID: 3941206
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiological evaluation of the Wolff-Parkinson-White syndrome: problems in assessing antegrade and retrograde conduction over the accessory pathway.
Svenson RH; Miller HC; Gallagher JJ; Wallace AG
Circulation; 1975 Oct; 52(4):552-62. PubMed ID: 1157268
[TBL] [Abstract][Full Text] [Related]
27. Drug-Induced Loss of Preexcitation in Pediatric Patients with WPW Pattern During Electrophysiologic Study.
Paech C; Wagner F; Strehlow V; Gebauer RA
Pediatr Cardiol; 2019 Jan; 40(1):194-197. PubMed ID: 30203293
[TBL] [Abstract][Full Text] [Related]
28. Surgical ablation of posterior septal accessory pathways in the Wolff-Parkinson-White syndrome by a closed heart technique.
Guiraudon GM; Klein GJ; Sharma AD; Jones DL; McLellan DG
J Thorac Cardiovasc Surg; 1986 Sep; 92(3 Pt 1):406-13. PubMed ID: 3528678
[TBL] [Abstract][Full Text] [Related]
29. Surgery for Wolff-Parkinson-White syndrome interrupts efferent vagal innervation to the left ventricle and to the atrioventricular node in the canine heart.
Inoue H; Mahomed Y; Kovacs RJ; Zipes DP
Cardiovasc Res; 1988 Mar; 22(3):163-70. PubMed ID: 3167940
[TBL] [Abstract][Full Text] [Related]
30. [Electrophysiological effects of sevoflurane in comparison with propofol in children with Wolff-Parkinson-White syndrome].
Pérez ER; Bartolomé FB; Carretero PS; Fernández CS; Mateos EJ; Tarlovsky LG
Rev Esp Anestesiol Reanim; 2008 Jan; 55(1):26-31. PubMed ID: 18333383
[TBL] [Abstract][Full Text] [Related]
31. [Effect of pharmacologic blockade of the autonomic nervous system on electrophysiologic properties of the accessory pathway and atrioventricular node in patients with Wolff-Parkinson-White syndrome].
Molenda W; Telichowski C; Banasiak W; Góral J; Petruk J; Zebrowski J
Kardiol Pol; 1989; 32(6):319-25. PubMed ID: 2632910
[TBL] [Abstract][Full Text] [Related]
32. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
[TBL] [Abstract][Full Text] [Related]
33. [Effect of aminophylline on electrophysiological characteristics of the accessory pathway in patients with Wolff-Parkinson-White syndrome].
Ostapiuk M; Telichowski C; Petruk J; Molenda W; Banasiak W
Kardiol Pol; 1988; 31(3):173-9. PubMed ID: 3221612
[No Abstract] [Full Text] [Related]
34. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
[TBL] [Abstract][Full Text] [Related]
35. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
Gulamhusein S; Ko P; Carruthers SG; Klein GJ
Circulation; 1982 Feb; 65(2):348-54. PubMed ID: 7053894
[TBL] [Abstract][Full Text] [Related]
36. Effect of verapamil on an accessory pathway manifesting as "fatigue phenomenon" in Wolff-Parkinson-White syndrome.
Fujimura O; Smith BA; Kuo CS
Chest; 1993 Jul; 104(1):305-7. PubMed ID: 8325098
[TBL] [Abstract][Full Text] [Related]
37. 'Hibernating' accessory pathway.
John B; Lokhandwala YY
Indian Heart J; 2006; 58(4):362-4. PubMed ID: 19039158
[TBL] [Abstract][Full Text] [Related]
38. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
[TBL] [Abstract][Full Text] [Related]
39. Effects of intravenous sotalol in patients with atrioventricular accessory pathways.
Touboul P; Atallah G; Kirkorian G; Lavaud P; Mathieu MP; Dellinger A
Am Heart J; 1987 Sep; 114(3):545-50. PubMed ID: 3630895
[TBL] [Abstract][Full Text] [Related]
40. Diprafenone for treatment of Wolff-Parkinson-White syndrome.
Kunze KP; Schlüter M; Geiger M; Kuck KH
Cardiovasc Drugs Ther; 1989 Mar; 3(1):73-9. PubMed ID: 2487525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
